TF and familial pancreatic carcinoma: Moreover, TF-targeted NIR-PIT demonstrated significant in vivo tumor control in murine xenograft models of pancreatic cancer and epithelioid cancer, as well as immunogenic cell death after treatment across multiple tumors.